Each month the FDA approves new medications, and below is a highlight of the most relevant new approvals and/or drugs which have the potential to impact your prescription plan. While the medications below have been evaluated and approved by the FDA, they may not enter the marketplace for several weeks or months. Therefore, pricing information for these medications is typically unavailable at the time of approval.
|New Brand Approvals|
|Drug Name||Uses/Treatment||Pricing Information||Other Information|
|Troxyca ER® (oxycodone and naltrexone) capsule||Treatment of adult patients with chronic pain for which alternative treatment options are inadequate.||Pricing information not yet available.||
|Erelzi™ (Etanercept-SZZS) injectable||Treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis in patient aged 2 years or older, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis||Pricing information not yet available.||
The Clinical Care Center (CCC) is MedTrakRx’s comprehensive clinical solution to control costs and increase adherence for our Clients and Members. The Clinical Care Center is made up of 7 Steps to Improved Outcomes: Generics Plus, Formulary Management, Member & Client Education, RightChoice, Control Trak, Best-In-Class (BIC) SpecialtyRx, and Clinical Concierge.